Fig. 5From: Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case reportPatient’s clinical course. Remarkable tumor shrinkage and normalization of serum CEA and NSE levels continue for more than 11 months. (CEA, serum carcinoembryonic antigen; NSE, serum neuron specific enolase)Back to article page